IP Verse

Mass Spectrometric Diagnosis Of Sepsis Without Blood Culture

Patent No. EP2601304 (titled "Mass Spectrometric Diagnosis Of Sepsis Without Blood Culture") was filed by Bruker Daltonics on Jul 29, 2011. The application was issued on Feb 18, 2026.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BIOMRIEUXJul 28, 2021SCHOEN
BIOMERIEUXJul 28, 2021-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2601304

BRUKER DALTONICS
Application Number
EP11749128A
Filing Date
Jul 29, 2011
Status
Patent Maintained As Amended
Jan 16, 2026
Publication Date
Feb 18, 2026
External Links
Slate, Register , Google Patents